Sertoli cell proliferation in the rat is completed by Days 15-20 postnatally. Thyroid hormones appear to regulate the duration of Sertoli cell proliferation, affecting adult Sertoli cell number and hence the capacity of the testis to produce sperm. In the present study, a combination of immunohistochemistry, immunoblot analysis, and reverse transcription-polymerase chain reaction was used to demonstrate the expression pattern of thyroid hormone receptors (TR) in the juvenile and adult rat testis. The results indicated that TR␣1 was expressed in proliferating Sertoli cell nuclei, its expression decreasing coincident with the cessation of proliferation. TR␣2, TR␣3, and TR␤1 mRNAs were expressed at low levels during development; however, the corresponding protein was not detected by immunoblot analysis. In addition, TR␣1 was found to be expressed in germ cells from intermediate spermatogonia to mid-cycle pachytene spermatocytes. Immunohistochemistry also demonstrated TR expression in a subset of interstitial cells. The demonstration of TR expression in germ cells undergoing spermatogenic differentiation suggests a possible role for thyroid hormones in the adult testis.
INTRODUCTION
In the rat, Sertoli cells proliferate only during the fetal and early neonatal periods before assuming a terminally differentiated state [1, 2] . The ultimate number of Sertoli cells in the adult testis is determined by both the rate and the duration of the proliferative phase. It has been demonstrated that each Sertoli cell is capable of supporting a limited number of germ cells through to maturity [3] [4] [5] [6] [7] ; hence Sertoli cell number determines the maximum spermatogenic potential of the testis. The hormonal factors controlling the rate and duration of Sertoli cell proliferation are therefore critical determinants of fertility. Previous studies have demonstrated that FSH is a mitogenic factor during the Sertoli cell proliferative phase [6, 8] , while thyroid hormones (triiodothyronine and thyroxine) influence the duration of proliferation [9] [10] [11] [12] [13] .
Neonatal hypothyroidism has been shown to lead to a prolongation of the period of Sertoli cell proliferation, giving rise to an increase in the numbers of Sertoli and germ cells, and a concomitant increase in testis size [10, 11, 14, 15] . Conversely, neonatal hyperthyroidism has been shown to lead to early cessation of Sertoli cell division, giving rise to decreased numbers of Sertoli and germ cells, and con- sequently a decrease in testis size [12, 16, 17] . Since these conditions influence Sertoli cell number, they also influence the capacity of the testis to produce sperm [3] [4] [5] [6] [7] 18] .
Thyroid hormone effects are mediated by thyroid hormone receptors (TR), which are members of the steroid receptor superfamily [19] . TR are encoded by two different genes: TR␣ and TR␤. Alternate splicing leads to the production of several peptide isoforms, five of which have been described: TR␣1, TR␣2, TR␣3, TR␤1, and TR␤2. TR␣2 and TR␣3, which lack a hormone-binding domain, are thought to function as inhibitors of thyroid hormone action by competition for the binding of thyroid response elements (TRE), resulting in suppression of transcription [20] [21] [22] [23] [24] [25] .
Early studies suggested that the adult testis is unresponsive to thyroid hormones [26, 27] . This observation was extrapolated to the developing animal, leading to the proposal of indirect mechanisms to explain the effects of thyroid hormones on Sertoli cell proliferation [28] . The cloning of cDNA encoding TR from a human testis expression library provided the first suggestion that thyroid hormones act directly on the testis [29] . Given the known effect of thyroid hormones on Sertoli cell development, a number of studies have investigated TR in the developing testis.
Binding studies have demonstrated specific thyroid hormone binding sites (presumed to be TR) in developing testes and Sertoli cell-enriched extracts. These binding sites were detected at very high levels in the fetus and early neonate, decreasing towards negligible expression at Day 20 postpartum (pp) [30, 31] -a pattern coincident with the proliferative phase of Sertoli cell development. Several molecular techniques have been used to demonstrate the presence of mRNA encoding TR␣ isoforms in fetal and neonatal testes [32] . Similar techniques indicate that TR␤ expression is present but significantly lower than TR␣ [32, 33] . These studies also suggest that TR expression is absent in the adult testis. In contrast, immunohistochemical data has shown the existence of TR in the adult testis, although the exact cellular localization remains unclear [34] [35] [36] .
The present study was undertaken to clarify the expression patterns of TR mRNA and protein in the rat testis during development and in the adult. We aimed to determine which TR isoforms are expressed in the developing and adult testis using a combination of reverse transcription (RT)-polymerase chain reaction (PCR) and immunoblot analysis. The localization of TR to nuclei within the seminiferous epithelium was achieved using immunohistochemistry.
MATERIALS AND METHODS

Tissue Collection
Male Sprague-Dawley rats were obtained from the Monash Central Animal house where they were kept on a 12L: 12D regime with food and water ad libitum. All experiments involving animals were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (1996; National Academy of Science, Washington, DC), and the studies were approved by the Monash University (Victoria, Australia) Department of Anatomy animal ethics committee. Tissue samples were collected from rats at Days 0, 5, 15, 25, and 63 pp. Rats were anesthetized with ether, and their abdominal and thoracic cavities were opened. For RT-PCR and immunoblot studies, testes, liver, kidneys, and/ or pituitary gland were removed, snap-frozen with liquid nitrogen, and stored at Ϫ75ЊC until required. For immunohistochemical studies, rats were perfused with heparin (25 000 IU/L; DBL, Melbourne, Australia) saline (0.9% NaCl) followed by PLP fixative (2% w:v paraformaldehyde, 0.075 M L-lysine, and 0.01 M periodate, all from Sigma (St. Louis, MO) via a needle into the left ventricle (pp Days 0 and 5 rats), or a catheter in the descending thoracic aorta (all other ages). The left testis was removed and processed to Paraplast paraffin wax (Oxford Labware, St. Louis, MO) for histology. Sections (5 m) were cut and mounted on Superfrost Plus slides (Biolab Scientific, Melbourne, Australia) for immunohistochemistry.
RT-PCR
RNA was extracted from testes and adult (Day 63) liver, kidneys, and brain using TRI reagent (Sigma), a modified form of the RNA extraction reagent designed by Chomczynski [37] . Polyadenylated mRNA was extracted from ϳ50 g adult rat pituitary tissue by solid-phase immobilization using Dynabeads oligo (dT) 25 magnetic beads (Dynal, Lake Success, CA). RT was performed for 50 min at 42ЊC using Superscript II (Life Technologies, Rockville, MD), primed with poly(dT) (Pharmacia, Uppsala, Sweden) and random hexamers (Pharmacia). The enzyme was heatinactivated by incubation at 70ЊC for 20 min.
PCR primers were designed using previously described TR sequences of human, rat, and mouse origin (Genbank accession numbers: TR␣1, J03819; TR␣2, J03239; TR␣3, X07752; TR␤1, J03933; TR␤2, M25071). Primers were designed using Primer3 [38] to cross exon-exon boundaries that differed between isoforms (Fig. 1A) . Primers were as follows: TR␣1 forward, TAGTCTCCGACGCCATCTTT; TR␣1 reverse, ACTTTCATGTGGAGGAAGCG; TR␣2/3 forward, GGCTGTGCTGCTAATGTCAA; TR␣2/3 reverse, AGACTTCCCGCTTCACCAAG; TR␤1 forward, CCAGACTTTCCAGACCGAAG; TR␤1 reverse, GCACT-GGTTACGGGTGACTT; TR␤2 forward, CATGGCCCT-GAGTCAGTACA; TR␤2 reverse, GCACTGGTTTAC-GGGTGACTT.
PCR was performed in a 50-l volume containing 1 unit of Taq polymerase (Pharmacia), 10 mM Tris-HCl, 1.5 mM MgCl 2 , 50 mM KCl, 0.2 mM dNTPs (Boehringer Mannheim, Mannheim, Germany), 1 M forward and reverse primers, and 1 g of cDNA from the RT reaction. The initial denaturation step was at 94ЊC for 3 min, followed by 35 cycles of denaturation for 30 sec at 94ЊC, annealing for 30 sec at 58ЊC, and extension for 1 min at 72ЊC. The solution was then subjected to 5 min of final extension at 72ЊC. PCR products were electrophoresed on a 1% agarose gel. Products were cloned using the TA cloning kit (Invitrogen, Carlsbad, CA), and the identity of cloned PCR products was confirmed by sequence analysis (data not shown).
Immunoblot Analysis
Protein was extracted from 100 mg of decapsulated testis tissue collected at various ages. Tissues were homogenized with lysis buffer (50 mM Tris, 0.1% SDS, pH 6.8) containing complete protease inhibitors (Boehringer Mannheim). After centrifugation, protein yield in the supernatant solution was determined by the Bio-Rad protein assay (BioRad, Hercules, CA). Fifty micrograms of protein was run in each well of a 10% polyacrylamide gel alongside 10 l of Bio-Rad prestained broad-range SDS-PAGE standard. Protein was transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA), which was then blocked for 15 min in blocking solution (2% skim milk powder, 0.1% Tween 20 in Tris-buffered saline), before incubation overnight at 4ЊC in 1:500 sc-772 (Santa-Cruz Biotechnologies, Santa-Cruz, CA) anti-TR␣1 antibody in blocking solution (sc-772 is raised to a full-length TR␣1 protein and is cross-reactive with TR␣ and TR␤ isoforms). The membrane was washed three times before incubation with a 1:10 000 dilution of horseradish peroxidase-conjugated goat anti-rabbit antibody (Silenus Laboratories, Melbourne, Australia) for 1 h at room temperature. Bound antibody was visualized using the enhanced chemiluminescence (ECL) Plus kit (Amersham, Uppsala, Sweden) according to the manufacturer's instructions.
Immunohistochemistry
Slides were dewaxed in three changes of Solvent 3B/ 2026 (HiChem, Melbourne, Australia), washed in three changes of ethanol, and rehydrated in distilled water. Slides were immersed in 400 ml of citrate buffer (0.01 M sodium citrate, pH 6.0) and microwaved for 10 min at 700 watts [39] . Slides were washed twice with PBS and blocked with CAS-blocking reagent (Zymed, San Francisco, CA) for 30 min at room temperature. All primary antibodies for immunohistochemistry were obtained from Affinity Bioreagents (Golden, CO) and were diluted 1:200 with 10% horse serum in PBS (for MA-216, monoclonal antibody raised to TR␤1) or 10% goat serum in PBS (for PA-210 and PA-214, polyclonal antibodies raised to all TR␣ isoforms and all TR isoforms, respectively). Slides treated with MA-216 (hereafter referred to as anti-␤1) were incubated for 14 h at 4ЊC. Slides treated with PA-210 (anti-␣) or PA-214 (anti-pan) were incubated for 2 h at room temperature. Negative control sections were treated with nonimmune serum diluted in the same manner. All subsequent detection steps were performed as previously described [30] . Sections were counterstained with Mayer's hematoxylin.
Slides were examined with a Leitz Diaplan microscope (Leica, Solms, Germany), and photomicrographs were taken using a Leitz Orthomat E camera. The stages of the cycle in the seminiferous epithelium were classified using the criteria described by Hess [40] .
RESULTS
Developmental Expression of TR Isoforms as Determined by RT-PCR and Immunoblot Analysis
Primer specificity was verified by amplification of cDNA from known positive tissue (brain, kidney, liver, and pituitary) from pp Day 63 rats and sequence analysis of the products. At least one TR isoform was amplified from each sample, verifying the validity of cDNA generated by the RT reaction. Previous studies have shown that TR␤1 is most highly expressed in liver, kidney, and brain [41] , while TR␤2 is almost exclusively expressed in the anterior pituitary gland [42] . All TR␣ isoforms are highly expressed in the brain, and TR␣1 is also highly expressed in muscle and brown fat [43] . Levels of expression found in testes at various ages were thus compared with expression in adult brain, liver, and pituitary tissue as high-expression controls.
TR␣1 mRNA expression was found to be high at Days 0, 5, and 25 pp, but lower at Day 15 pp and Day 63 pp (Fig. 1B) . TR␣2 and TR␣3 mRNA expression decreased steadily from high levels at Day 0 pp until both were undetectable by Day 63 pp. TR␣2 expression appeared to exceed TR␣3 expression at all ages tested (Fig. 1B) . TR␤1 mRNA was found to be expressed at very low levels at Days 5 and 25 pp but was absent at all other ages surveyed (Fig. 1B) . TR␤2 expression was absent at all ages (data not shown).
Immunoblot analysis indicated that TR␣1 (indicated by a 47-kDa band) was expressed throughout development and in the adult testis (Fig. 2) . TR␣2, TR␤1, and TR␤2, which would have displayed 55-, 53-, and 58-kDa bands, respectively, were undetectable by immunoblot analysis at any of the ages surveyed. TR␣3, which would exhibit a band of 47 kDa, was undistinguishable from TR␣1. In combination, the RT-PCR and immunoblot analysis of total testis extracts suggests that TR␣1 is the dominant TR isoform regulating testis development.
Developmental Expression of TR as Determined by Immunohistochemistry
Expression of TR in Sertoli cells. In pp Day 0 and 5 testes, all antibodies resulted in strong staining of Sertoli cell nuclei (Fig. 3, A and B) . Faint cytoplasmic staining was observed at Day 0 pp but was less obvious at other ages surveyed. At Day 15 pp, staining of Sertoli cell nuclei became punctate and peripheral (Fig. 3C) . At Days 25 and 63 pp, Sertoli cells exhibited little staining, apart from that occasionally observed within the nucleolus (Fig. 3, D-G) .
Expression of TR in germ cells. At Days 0 and 5 pp, gonocytes were negative for all antibodies tested (Fig. 3, A  and B) . At later ages, germ cell staining was cell typespecific; staining was first apparent in intermediate (using anti-␤1 and anti-pan antibodies) or type B spermatogonia (using anti-␣ antibody), and appeared in pachytene spermatocytes associated with stage III at Day 15 pp (the most advanced germ cells present at this age), and in pachytene spermatocytes in stage VII-IX at Days 25 and 63 pp (Fig.  3, C-G) . Some staining was also noted in residual bodies of cytoplasm being phagocytosed by Sertoli cells (Fig. 3F) . Cell type specificity was dependent upon the antibody used: anti-pan staining was seen from intermediate spermatogonia to pachytene spermatocytes in stage IX, while anti-␤1 positivity was present only up to zygotene spermatocytes in stage XIII or early pachytene spermatocytes in stage XIV. Figure 4 illustrates the cell type-specific staining patterns observed in relation to the stages of the spermatogenic cycle as described by Dym and Clermont [44] .
Expression of TR in interstitial cells. Because of the fixation and antigen retrieval protocols used, most interstitial cells could not be characterized by morphological criteria. At Days 0 and 5 pp, almost all interstitial cells were positively stained with each antibody used. At Days 15, 25, and 63 pp, only a small proportion of interstitial cells were positively stained (data not shown). Some vascular endothelial cells were stained at all ages surveyed.
DISCUSSION
In this study, we have demonstrated the expression pattern of TR in the developing and adult rat testis. We found that TR, predominantly TR␣1, are expressed in all Sertoli cells during the proliferative phase of their development. A novel finding is that spermatogenic germ cells between intermediate spermatogonia and pachytene spermatocytes also express TR␣1.
RT-PCR and immunoblot analysis demonstrated that TR␣1 is expressed throughout development and in the adult testis. The fluctuating levels of TR␣1 expression shown by RT-PCR are likely to reflect the dilution of TR-positive cell types by other cells: At Day 15, Sertoli cells appeared to be switching off TR expression, reflected by a weak RT-PCR signal, while at Day 63, TR-positive cells were diluted by large numbers of spermatids. The absence of bands on an immunoblot corresponding to any TR isoform other than TR␣1 suggests that TR␣1 is the predominant isoform expressed in the testis. RT-PCR demonstrated expression of mRNA encoding TR␣2, TR␣3, and TR␤1; however, immunoblot data suggests that, if expressed, the corresponding peptide is present at relatively low levels.
Immunohistochemical data clearly show that TR are expressed in Sertoli cell nuclei during their proliferative phase. The punctate staining pattern observed in pp Day 15 Sertoli cells is in agreement with previous studies that report decreasing levels of TR expression in Sertoli cells as the testis approaches Day 20 pp [30, 31] . The absence of immunoreactive TR in Sertoli cell nuclei after this age supports the notion that there is a critical window for modifying thyroid hormone levels to affect Sertoli cells [45] .
In light of the effects of thyroid hormone on Leydig cells [46] [47] [48] [49] [50] [51] , it seems likely that in the interstitium, TR are expressed in Leydig cells. The decreasing TR␣2 and TR␣3 mRNA expression demonstrated by RT-PCR matches the immunohistochemical staining pattern of interstitial cells; however, immunoblot analysis indicates that neither isoform is highly expressed. We therefore conclude that TRpositive interstitial cells primarily express TR␣1 protein but may also express TR␣2 and TR␣3 at low levels.
The immunohistochemical demonstration of TR␤1 expression in immature Sertoli cells and spermatogenic germ cells seems to conflict with RT-PCR and immunoblot data demonstrating low levels of TR␤1 mRNA and undetectable levels of TR␤1 protein in the whole testis. We believe that this disparity is due to the high sensitivity of the immunohistochemical staining method used. This suggests that TR␤1 is expressed at very low levels that are redundant in relation to TR␣1 expression. This is further substantiated by the findings of Jannini et al. [32] showing that TR␤ mRNA is undetectable by Northern, in situ, and ribonuclease (RNase) protection analyses, while Palmero et al. [33] demonstrated that TR␤1 is detectable only after 30 cycles of PCR amplification.
Van Haaster et al. [11, 12] , and Simorangkir et al. [7] showed that modification of thyroid hormone levels leads to an increase in germ cell degeneration in the juvenile rat. This effect was attributed to the inability of undifferentiated Sertoli cells (in hypothyroid juveniles) to support spermatogenesis, or the lack of sufficient numbers of Sertoli cells (in hyperthyroid animals) to support large numbers of germ cells. The demonstration of TR expression in germ cells leads us to speculate that thyroid hormones could act as a moderator of germ cell survival. The apparent conflict between the demonstration of TR expression in germ cells and the absence of specific thyroid hormone binding sites in the adult testis [30, 31] could be due to the dilution of TR-positive cells by the abundance of TR-negative cells such as round and elongating spermatids and Sertoli cells.
These data indicate that TR␣1 is the predominant TR isoform expressed in the developing and adult testis. The expression of TR in proliferating Sertoli cell nuclei is consistent with its role in regulating the process of Sertoli cell division. The presence of TR in germ cells from intermediate spermatogonia to spermatocytes suggests a possible role in normal spermatogenesis that has yet to be examined.
